Literature DB >> 17689495

Heparanase induces Akt phosphorylation via a lipid raft receptor.

Olga Ben-Zaken1, Svetlana Gingis-Velitski, Israel Vlodavsky, Neta Ilan.   

Abstract

The endoglycosidase heparanase is the predominant enzyme that degrades heparan sulfate side chains of heparan sulfate proteoglycans, activity that is strongly implicated in tumor metastasis. Apart of its well characterized enzymatic activity, heparanase was noted to exert also enzymatic-independent functions. Among these is the induction of Akt/PKB phosphorylation noted in endothelial- and tumor-derived cells. Protein domains of heparanase required for signaling were not identified to date, nor were identified heparanase binding proteins/receptors capable of transmitting heparanase signals. Here, we examined the possible function of mannose 6-phosphate receptor (MPR) and low-density lipoprotein-receptor related protein (LRP), recently implicated in cellular uptake of heparanase, as heparanase receptors mediating Akt phosphorylation. We found that heparanase addition to MPR- and LRP-deficient fibroblasts elicited Akt activation indistinguishable from control fibroblasts. In contrast, disruption of lipid rafts abrogated Akt/PKB phosphorylation following heparanase addition. These results suggest that lipid raft-resident receptor mediates heparanase signaling.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17689495      PMCID: PMC2390716          DOI: 10.1016/j.bbrc.2007.06.188

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Molecular properties and involvement of heparanase in cancer metastasis and angiogenesis.

Authors:  I Vlodavsky; Y Friedmann
Journal:  J Clin Invest       Date:  2001-08       Impact factor: 14.808

2.  Heparanase mediates cell adhesion independent of its enzymatic activity.

Authors:  Orit Goldshmidt; Eyal Zcharia; Miriam Cohen; Helena Aingorn; Irit Cohen; Liat Nadav; Ben-Zion Katz; Benjamin Geiger; Israel Vlodavsky
Journal:  FASEB J       Date:  2003-06       Impact factor: 5.191

3.  Cellular heparan sulfate participates in the metabolism of prions.

Authors:  Olga Ben-Zaken; Salit Tzaban; Yuval Tal; Lior Horonchik; Jeffrey D Esko; Israel Vlodavsky; Albert Taraboulos
Journal:  J Biol Chem       Date:  2003-07-18       Impact factor: 5.157

4.  Clustering induces redistribution of syndecan-4 core protein into raft membrane domains.

Authors:  Eugene Tkachenko; Michael Simons
Journal:  J Biol Chem       Date:  2002-03-11       Impact factor: 5.157

5.  Cross-talk between caveolae and glycosylphosphatidylinositol-rich domains.

Authors:  L Abrami; M Fivaz; T Kobayashi; T Kinoshita; R G Parton; F G van der Goot
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

6.  Cholesterol-rich lipid rafts mediate akt-regulated survival in prostate cancer cells.

Authors:  Liyan Zhuang; Jianqing Lin; Michael L Lu; Keith R Solomon; Michael R Freeman
Journal:  Cancer Res       Date:  2002-04-15       Impact factor: 12.701

Review 7.  Ten years of protein kinase B signalling: a hard Akt to follow.

Authors:  D P Brazil; B A Hemmings
Journal:  Trends Biochem Sci       Date:  2001-11       Impact factor: 13.807

8.  Identification of a plasma membrane Raft-associated PKB Ser473 kinase activity that is distinct from ILK and PDK1.

Authors:  Michelle M Hill; Jianhua Feng; Brian A Hemmings
Journal:  Curr Biol       Date:  2002-07-23       Impact factor: 10.834

9.  Heparanase affects adhesive and tumorigenic potential of human glioma cells.

Authors:  Anna Zetser; Yulia Bashenko; Hua-Quan Miao; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2003-11-15       Impact factor: 12.701

10.  Heparan sulphate proteoglycans modulate fibroblast growth factor-2 binding through a lipid raft-mediated mechanism.

Authors:  Chia Lin Chu; Jo Ann Buczek-Thomas; Matthew A Nugent
Journal:  Biochem J       Date:  2004-04-15       Impact factor: 3.857

View more
  25 in total

1.  The endoglycosidase heparanase enters the nucleus of T lymphocytes and modulates H3 methylation at actively transcribed genes via the interplay with key chromatin modifying enzymes.

Authors:  Yi Qing He; Elissa L Sutcliffe; Karen L Bunting; Jasmine Li; Katharine J Goodall; Ivan K A Poon; Mark D Hulett; Craig Freeman; Anjum Zafar; Russell L McInnes; Toshiki Taya; Christopher R Parish; Sudha Rao
Journal:  Transcription       Date:  2012 May-Jun

2.  Characterization of heparanase-induced phosphatidylinositol 3-kinase-AKT activation and its integrin dependence.

Authors:  Anjum Riaz; Neta Ilan; Israel Vlodavsky; Jin-Ping Li; Staffan Johansson
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

Review 3.  Tumorigenic and adhesive properties of heparanase.

Authors:  Flonia Levy-Adam; Neta Ilan; Israel Vlodavsky
Journal:  Semin Cancer Biol       Date:  2010-07-07       Impact factor: 15.707

4.  Processing of heparanase is mediated by syndecan-1 cytoplasmic domain and involves syntenin and α-actinin.

Authors:  Anna Shteingauz; Neta Ilan; Israel Vlodavsky
Journal:  Cell Mol Life Sci       Date:  2014-05-01       Impact factor: 9.261

5.  Heparanase induces signal transducer and activator of transcription (STAT) protein phosphorylation: preclinical and clinical significance in head and neck cancer.

Authors:  Victoria Cohen-Kaplan; Jenny Jrbashyan; Yoav Yanir; Inna Naroditsky; Ofer Ben-Izhak; Neta Ilan; Ilana Doweck; Israel Vlodavsky
Journal:  J Biol Chem       Date:  2011-12-22       Impact factor: 5.157

Review 6.  Proteoglycans in health and disease: new concepts for heparanase function in tumor progression and metastasis.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Ilana Dowek; Ralph D Sanderson; Neta Ilan; Israel Vlodavsky
Journal:  FEBS J       Date:  2010-08-31       Impact factor: 5.542

7.  Heparanase augments epidermal growth factor receptor phosphorylation: correlation with head and neck tumor progression.

Authors:  Victoria Cohen-Kaplan; Ilana Doweck; Inna Naroditsky; Israel Vlodavsky; Neta Ilan
Journal:  Cancer Res       Date:  2008-12-15       Impact factor: 12.701

8.  A novel human heparanase splice variant, T5, endowed with protumorigenic characteristics.

Authors:  Uri Barash; Victoria Cohen-Kaplan; Gil Arvatz; Svetlana Gingis-Velitski; Flonia Levy-Adam; Ofer Nativ; Ronen Shemesh; Michal Ayalon-Sofer; Neta Ilan; Israel Vlodavsky
Journal:  FASEB J       Date:  2009-12-09       Impact factor: 5.191

9.  Heparanase promotes engraftment and prevents graft versus host disease in stem cell transplantation.

Authors:  Menachem Bitan; Lola Weiss; Michael Zeira; Eyal Zcharia; Shimon Slavin; Arnon Nagler; Israel Vlodavsky
Journal:  PLoS One       Date:  2010-04-15       Impact factor: 3.240

Review 10.  Heparanase: busy at the cell surface.

Authors:  Liat Fux; Neta Ilan; Ralph D Sanderson; Israel Vlodavsky
Journal:  Trends Biochem Sci       Date:  2009-09-03       Impact factor: 13.807

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.